Abstract
Objective
The role of signal transducer and activator of transduction (STAT) 4 vs. 6 has been assessed thus far only in a model of high mortality strongly driven by proinflammation alone. Their role in a low-mortality (LD25) model of sepsis remains unclear.
Design and setting
Prospective controlled animal study in a research laboratory.
Subjects
STAT4 and STAT6 knockout mice.
Interventions
We induced sepsis by cecal ligation and puncture (CLP) or sham CLP in three groups of mice: (a) STAT4−/−, (b) STAT6−/−, (c) BALB/c. Splenic T cells or macrophages were then harvested 24 h after CLP, and their ability to produce cytokines was assessed.
Results
Following CLP T-cells from BALB/c mice were suppressed in the ability to release the Th1 cytokines interleukin (IL) 2 and interferon γ. The release of Th2 cytokine IL-10 was increased. The Th1 response of STAT4-deficient animals was not only markedly lower in shams but was further suppressed by CLP. The Th2 cytokine response was elevated even more than that of the septic BALB/c. This was associated with lower survival than in the BALB/c. STAT6 deficiency resulted in a stronger Th1 response and a suppressed Th2 response to CLP. A similar difference between IL-12 and IL-10 release was seen in macrophages from these mice. Interestingly, while this resulted in improved survival, compared to STAT4−/− mice, the STAT6−/− animals still had a higher mortality than the BALB/c.
Conclusions
These data suggest that contributions from both STAT4 driven processes as well as STAT6 responses are needed in a balanced fashion to maximize the animals’ ability to survive septic challenge.
Similar content being viewed by others
References
Mannick JA (1993) Trauma, sepsis and immune defects. In: Faist E, Meakins JL, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis.– Springer, Berlin Heidelberg New York, pp 15–21
Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH (1994) Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579–585
O’Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482–492
DiPiro JT, Howdieshell TR, Goddard JK, Callaywa DB, Hamilton RG, Mansberger AR (1998) Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130:1159–1163
Ferguson NR, Galley HF, Webster NR (1999) T helper subset ratios in patients with severe sepsis. Intensive Care Med 25:106–109
Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS (2005) High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 31:401–407
Song GY, Chung CS, Chaudry IH, Ayala A (2000) IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128:133–138
Biron CA, Gazzinelli RT (1995) Effect of IL-12 on immune responses to microbial infections: a key mediator in regulating diseases outcome. Curr Opin Immunol 7:485–496
O’Suilleabhain C, O’Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML (1996) Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120:290–296
Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL (1999) Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437–5443
Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW, Kunkel SL (2001) Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med 193:679–688
Godshall CJ, Lentsch AB, Peyton JC, Scott MJ, Cheadle WG (2001) STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin Diagn Lab Immunol 8:1044–1048
Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602–3610
Barriere SL, Lowry SF (1995) An overview of mortality risk prediction in sepsis. Crit Care Med 23:376–393
Abraham E (1999) Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25:556–566
Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 1998 9:1–11
Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH (1992) Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191–199
Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331–335
Meldrum DR, Ayala A, Perrin MM, Ertel W, Chaudry IH (1991) Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res 51:158–164
Ayala A, Lehman DL, Herdon CD, Chaudry IH (1994) Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin (IL)-10 suppression of T-cell response is mediated by eicosanoid induced IL-4 release. Arch Surg 129:1172–1178
Godshall CJ, Scott MJ, Peyton JC, Gardner SA, Cheadle WG (2002) Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 102:45–49
Song GY, Chung CS, Chaudry IH, Ayala A (1999) What is IL-10’s role in polymicrobial sepsis: anti-inflammatory agent or immune suppressant? Surgery 126:378–383
Lederer JA, Rodrick ML, Mannick JA (1999) The effects of injury on the adaptive immune response. Shock 11:153–159
Ayala A, Chung CS, Song GY, Grutkoski PS, Simms HH (2003) Down-regulation of the immune response. In: Linden P, Doughty LA (eds) Molecular & cellular biology of critical care medicine.–. Kluwer, Norwell, pp 41–78
Ayala A, Chung CS, Song GY (1999) Lymphocyte activation, anergy, and apoptosis in polymicrobial sepsis. In: Marshall JC, Cohen J (eds) Immune response in the critically ill– Springer, Berlin Heidelberg New York, pp 227–245
Hotchkiss RS, Karl IE (2003) Medical progress: the pathophysiology and treatment of sepsis. N Engl J Med 348:138–150
Leonard WL, O’Shea JJ (1998) Jaks and Stats: biological implications. Annu Rev Immunol 16:293–322
Kaplan MH, Grusby MJ (1998) Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol 64:2–5
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S (1996) Essential role of Stat6 in IL-4 signaling. Nature 380:627–630
Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML, Pargellis CA (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4:311–318
Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603–6610
Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106–110
Zellweger R, Ayala A, Chaudry IH (1998) Predisposing factors: effects of sex, nutritional factors and age on immunity following shock and sepsis. In: Redl H, Schlag G (eds) Cytokines in severe sepsis and septic shock. Birkhauser, Basel, pp 57–77
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported by grant R01 GM46354 (A.A.) from the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Song, G.Y., Chung, CS., Rhee, R.J. et al. Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis. Intensive Care Med 31, 1564–1569 (2005). https://doi.org/10.1007/s00134-005-2793-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-2793-z